Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Weight gain around menopause can be difficult to deal with, but it doesn’t have to be. A team of epidemiologists, nutritionists and women’s health experts from the National University of Singapore and Harvard University, USA have come together to figure out which dietary habits and healthy eating plans help women stay trim and avoid weight […]

The post Prevent menopause weight gain with these science approved diet hacks appeared first on Medical News Bulletin.

Migraine with aura was associated with an increased risk for incident ischemic stroke in middle-aged adults, with no difference among Black and white patients, according to a study published in Neurology Open Access.
Lead study author Adam S. Sprouse Blum, MD, PhD, clinical instructor at the Larner College of Medicine at the University of Vermont, and colleagues further found that any migraine with or without aura was linked to a greater risk for ischemic stroke in men aged younger than 72 years, which was not found in women or older men. The study authors called this finding “contrary to

The FDA expanded its approval of linaclotide to include pediatric patients aged 2 to 5 years with functional constipation.
Linaclotide (Linzess, Ironwood Pharmaceuticals) received FDA approval in November 2025 for children aged 6 years and older with functional constipation. The guanylate cyclase-C agonist is prescribed as a once-daily 72 µg capsule.
“Managing functional constipation in young children is especially challenging, as this vulnerable patient population often continues to experience persistent symptoms despite treatment with over-the-counter therapies,” Julie Khlevner, MD, a

Epioxa improved corneal curvature and demonstrated visual acuity gains and safety in pediatric patients with keratoconus, according to a presenter at the American Association for Pediatric Ophthalmology and Strabismus meeting.
Michael B. Raizman, MD, of Ophthalmic Consultants of Boston, presented the results of a subgroup analysis of a phase 3 multicenter trial in which 30 eyes of 22 pediatric patients between the age of 13 to 17 years old were assigned to 2:1 treatment with Epioxa (riboflavin 5’-phosphate ophthalmic solution 0.239% and 0.177%, Glaukos), the first epithelium-on cross-linking

The medications most likely to cause thyroid eye disease are alemtuzumab, certain immune checkpoint inhibitors, amiodarone and lenalidomide, according to a review in Graefe’s Archive for Clinical and Experimental Ophthalmology.
“Medication-associated TED is an important diagnostic consideration in orbital inflammatory disease,” Terence Ang, PhD, of University of Adelaide, Australia, and colleagues wrote, adding that it “is rare and has been described as an [adverse effect] for several medications, particularly the class of monoclonal antibodies.”
To find out which

FORT LAUDERDALE, Fla. — An intravitreal insert provides durable control of multiple retinal diseases, according to a presentation at Retina World Congress.
Ashkan M. Abbey, MD, FASRS, FAAO, told Healio that EYP-1901, also known as Duravyu (vorolanib intravitreal insert, EyePoint Pharmaceuticals), works by inhibiting the intracellular pan-VEGF receptor as well as the PDGF receptor while interacting with the JAK1 receptor. This “multimechanism of action” is designed to treat retinal vascular diseases, he said.
“It uses a bioerodible matrix to consistently elute the drug vorolanib, which is a

A 75-year-old man was brought to the office by his wife of 50 years for follow up after experiencing a very frightening event.
The patient and his wife were exercising at a local health club 3 days ago for their usual 2-hour workout. They typically walk on the treadmill for about an hour and then stretch before lifting 10- to 15-lb weights. They have been doing this for about 3 days per week for the last few years.
About 30 minutes into the weight portion of the workout, the patient began acting strangely. He asked his wife where they were, and when she responded, he repeatedly asked, “Why are

The American Cancer Society updated its colorectal cancer screening guideline to reflect molecular-based screening tests that received regulatory approval in the past few years.
The guideline — last updated in 2018 — now includes additional information about at-home multitarget stool tests. It also addresses a blood-based test that is administered in a physician’s office, though guideline authors recommend this only for individuals who decline all other forms of screening.
The changes reflect “the importance of options” and ensure screening-eligible individuals can make informed choices,

Measures of ideal heart health including healthy levels of physical activity, BMI, BP and sleep were associated with lower risk for severe COVID-19 among people with no history of heart disease during the pandemic, researchers reported.
For every 1 standard deviation increase in total American Heart Association’s Life’s Essential 8 score, individuals without prior CVD experienced an approximately 20% reduced risk for severe COVID-19 infection, according to data published in the Journal of the American Heart Association.
“What's well known in COVID epidemiology research at this point is that

A specially tailored cognitive behavioral therapy intervention may reduce insomnia and hot flashes among perimenopausal and postmenopausal women, researchers reported from a small pilot trial published in Menopause.
Sara Nowakowski, PhD, associate professor and psychologist at Baylor College of Medicine, said several clinical trials have found that cognitive behavioral therapy (CBT) may benefit women experiencing insomnia during menopause. Nowakowski said vasomotor symptoms and sleep disturbances are among the most common complaints from women during menopause, leading researchers to assess